Pegylated interferon alpha 2b (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2b for chronic hepatitis C in HIV patients

被引：0
|
作者：
Cargnel, A
Angeli, E
Mainini, A
Gubertini, G
Giorgi, R
Orlando, G
Duca, P
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)83871-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A766 / A766
页数：1
相关论文
共 50 条
  • [41] Interferon Alpha 2b in Combination with Ribavirin as a Treatment for Chronic Hepatitis C
    Mandokhel, Sherbet Khan
    Aziz-U-Rehman
    Khan, Mohammad Saleem
    Azeemullah
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2011, 5 (01): : 168 - 171
  • [42] Gene expression profiles of patients with chronic hepatitis C (CH-C) treated with pegylated interferon alfa-2b and ribavirin (PEG-IFN/RBV)
    Younossi, ZM
    Chan, J
    Schlauch, K
    Assmann, J
    Santini, C
    Ong, J
    Martin, L
    Gramlich, T
    McAllister, L
    Chang, SY
    GASTROENTEROLOGY, 2004, 126 (04) : A719 - A720
  • [43] Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus
    Hashimoto, Yuki
    Kanto, Hiromi
    Itoh, Masatoshi
    JOURNAL OF DERMATOLOGY, 2007, 34 (08): : 577 - 582
  • [44] New-Onset Psoriasis Following Treatment with Pegylated Interferon-Alpha 2b and Ribavirin for Chronic Hepatitis C
    Horev, Amir
    Halevy, Sima
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2009, 11 (12): : 760 - 761
  • [45] Preliminary treatment results of pegylated interferon alpha 2b and ribavirin in liver transplant recipients with recurrent hepatitis C virus nonresponsive to interferon alpha2b and ribavirin
    Neff, GW
    Montalbano, M
    Ozden, N
    Muslu, H
    Lee, YM
    Safdar, K
    Morrero, R
    Nery, J
    Weppler, D
    Madariaga, J
    Levi, D
    Nashida, S
    Kato, T
    Schiff, E
    Tzakis, A
    JOURNAL OF HEPATOLOGY, 2003, 38 : 160 - 160
  • [46] COST-EFFECTIVENESS OF PEG-IFN ALPHA 2A OR 2B PLUS RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C IN MEXICO
    Salinas Escudero, G.
    Idrovo, J.
    Rivas, R.
    Ramirez Rodriguez, J.
    Rico Alba, I. A.
    Zapata, L.
    VALUE IN HEALTH, 2009, 12 (03) : A59 - A59
  • [47] COST-EFFECTIVENESS OF PEG-IFN ALPHA 2A OR 2B PLUS RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C IN MEXICO
    Salinas Escudero, G.
    Idrovo, J.
    Rivas, R.
    Ramirez Rodriguez, J.
    Rico Alba, I. A.
    Zapata, L.
    VALUE IN HEALTH, 2009, 12 (07) : A508 - A508
  • [48] Differing immune effects of PEG-IFN-alpha 2b and IFN-alpha 2b combined with ribavirin for chronic hepatitis C
    Ishii, K
    Sumino, Y
    Higami, K
    Fujita, Y
    Shinohara, M
    Ikehara, T
    Shinohara, M
    Matsumaru, K
    Nagai, H
    Watanabe, M
    Miki, K
    HEPATOLOGY, 2005, 42 (04) : 677A - 678A
  • [49] Clinical characteristics of null responders to Peg-IFN alpha 2b/ribavirin therapy for chronic hepatitis C
    Suzuki, Hideyuki
    Kakizaki, Satoru
    Horiguchi, Norio
    Ichikawa, Takeshi
    Sato, Ken
    Takagi, Hitoshi
    Mori, Masatomo
    WORLD JOURNAL OF HEPATOLOGY, 2010, 2 (11) : 401 - 405
  • [50] Treatment with pegylated interferon alpha 2b and ribavirin in patients unresponsive to previous treatments with standard interferon as monotherapy or combined with ribavirin
    Carnicer, F
    Zapater, P
    Gutiérrez, A
    García, A
    Ruiz, F
    López, M
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2005, 97 (05) : 306 - 316
12345